Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 10-2019 | 07-2019 | 04-2019 | 01-2019 | 10-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,492 | 4,397 | 3,822 | 4,153 | 3,056 |
| Marketable Securities | 2,350 | 2,100 | 2,750 | 1,750 | 2,000 |
| Receivables | 67 | 1 | 797 | N/A | 307 |
| TOTAL | $6,093 | $6,628 | $7,494 | $6,236 | $5,538 |
| Non-Current Assets | |||||
| PPE Net | 201 | 215 | 230 | 67 | 73 |
| Intangibles | 0 | 0 | 42 | 168 | 838 |
| TOTAL | $201 | $215 | $272 | $234 | $910 |
| Total Assets | $6,294 | $6,843 | $7,765 | $6,470 | $6,449 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 586 | 568 | 718 | 613 | 582 |
| Accrued Expenses | 896 | 876 | 878 | 714 | 683 |
| TOTAL | $1,481 | $1,444 | $1,596 | $1,327 | $1,265 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 24 | 26 | 37 | 85 | 89 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,481 | $1,444 | $1,596 | $1,327 | $1,265 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,821 | 20,207 | 20,097 | 19,628 | 19,292 |
| Common Shares | 203 | 202 | 200 | 195 | 189 |
| Retained earnings | -181,817 | -179,730 | -177,590 | -175,052 | -170,170 |
| Other shareholders' equity | -423 | -399 | -373 | -336 | -251 |
| TOTAL | $4,812 | $5,399 | $6,170 | $5,143 | $5,183 |
| Total Liabilities And Equity | $6,294 | $6,843 | $7,766 | $6,470 | $6,449 |